IFNG and neoplasm: It was noted that the loss of function mutations in the genes encoding JAK1 or JAK2 resulted in a lack of response to IFN-γ, affects the antiproliferative effects on tumor cells, and thereby affects the response to ICI therapy in malignancies[53].